Cargando…

Role of Galectins in the Liver Diseases: A Systematic Review and Meta-Analysis

Background: Galectins, a family of β-galactoside-binding proteins, are related to the development and progression of various human diseases such as cancer, heart failure, and chronic kidney disease. However, its role in liver diseases is unclear. Methods: The PubMed, Embase, and Cochrane Library dat...

Descripción completa

Detalles Bibliográficos
Autores principales:	An, Yang, Xu, Shixue, Liu, Yiting, Xu, Xiangbo, Philips, Cyriac Abby, Chen, Jiang, Méndez-Sánchez, Nahum, Guo, Xiaozhong, Qi, Xingshun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8578830/ https://www.ncbi.nlm.nih.gov/pubmed/34778306 http://dx.doi.org/10.3389/fmed.2021.744518

Ejemplares similares

Association of C-type lectin-like receptor 2 and galectin-1 with portal vein system thrombosis in HBV-related liver cirrhosis
por: Zhang, Yiyan, et al.
Publicado: (2023)

Galectins for Diagnosis and Prognostic Assessment of Human Diseases: An Overview of Meta-Analyses
por: Liu, Yiting, et al.
Publicado: (2020)

Effects of Short-Term Human Albumin Infusion for the Prevention and Treatment of Hyponatremia in Patients with Liver Cirrhosis
por: Bai, Zhaohui, et al.
Publicado: (2022)

No Benefit of Hemostatic Drugs on Acute Upper Gastrointestinal Bleeding in Cirrhosis
por: An, Yang, et al.
Publicado: (2020)

Timing of endoscopy in patients with cirrhosis and acute variceal bleeding: a single-center retrospective study
por: Peng, Mengyuan, et al.
Publicado: (2023)

Association of thromboelastography profile with severity of liver cirrhosis and portal venous system thrombosis
por: He, Yanglan, et al.
Publicado: (2021)

No Association of Homocysteine, Anticardiolipin Antibody, and Anti-β2 Glycoprotein I Antibody With Portal Venous System Thrombosis in Liver Cirrhosis
por: Wang, Le, et al.
Publicado: (2021)

Impact of spider nevus and subcutaneous collateral vessel of chest/abdominal wall on outcomes of liver cirrhosis
por: Li, Hongyu, et al.
Publicado: (2018)

Role of Terlipressin in Cirrhotic Patients with Ascites and without Hepatorenal Syndrome: A Systematic Review of Current Evidence
por: Bai, Zhaohui, et al.
Publicado: (2020)

Association of coagulopathy with the risk of bleeding after invasive procedures in liver cirrhosis
por: Li, Jing, et al.
Publicado: (2018)

Evolution of Nonmalignant Portal Vein Thrombosis in Liver Cirrhosis: A Pictorial Review
por: Xu, Shixue, et al.
Publicado: (2021)

Relationship of Helicobacter pylori Infection with Nonalcoholic Fatty Liver Disease: A Meta-Analysis
por: Xu, Guangqin, et al.
Publicado: (2023)

U‐shaped relationship between subcutaneous adipose tissue index and mortality in liver cirrhosis
por: Zhu, Menghua, et al.
Publicado: (2022)

Anticoagulation Favors Thrombus Recanalization and Survival in Patients With Liver Cirrhosis and Portal Vein Thrombosis: Results of a Meta-Analysis
por: Wang, Le, et al.
Publicado: (2020)

Incidence, risk factors, and prognosis of abnormal liver biochemical tests in COVID-19 patients: a systematic review and meta-analysis
por: Wu, Yanyan, et al.
Publicado: (2020)

Nonselective β-Blockers May Progress the Thrombosis of Portal Venous System in Cirrhotic Patients: A Retrospective Observational Study
por: Xu, Xiangbo, et al.
Publicado: (2020)

Liver Involvement in Erythropetic Protoporphyria
por: Philips, Cyriac Abby, et al.
Publicado: (2016)

Child–Pugh Versus MELD Score for the Assessment of Prognosis in Liver Cirrhosis: A Systematic Review and Meta-Analysis of Observational Studies
por: Peng, Ying, et al.
Publicado: (2016)

Use of nonselective β blockers after variceal eradication in cirrhotic patients undergoing secondary prophylaxis of esophageal variceal bleeding: a critical review of current evidence
por: Xu, Xiangbo, et al.
Publicado: (2019)

Prevalence of Splanchnic Vein Thrombosis in Pancreatitis: A Systematic Review and Meta-Analysis of Observational Studies
por: Xu, Wenda, et al.
Publicado: (2015)

Epidemiology and Risk Factors of Portal Venous System Thrombosis in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
por: Lin, Hanyang, et al.
Publicado: (2022)

Still 'dwelling in the possibility' - critical update on stem cell therapy for acute on chronic liver failure
por: Philips, Cyriac Abby, et al.
Publicado: (2020)

Human albumin infusion strategy in liver cirrhosis: liberal or restrictive?
por: Bai, Zhaohui, et al.
Publicado: (2021)

Role of D-dimer in the Development of Portal Vein Thrombosis in Liver Cirrhosis: A Meta-analysis
por: Dai, Junna, et al.
Publicado: (2015)

Diagnostic Accuracy of APRI, AAR, FIB-4, FI, King, Lok, Forns, and FibroIndex Scores in Predicting the Presence of Esophageal Varices in Liver Cirrhosis: A Systematic Review and Meta-Analysis
por: Deng, Han, et al.
Publicado: (2015)

Albumin infusion may decrease the incidence and severity of overt hepatic encephalopathy in liver cirrhosis
por: Bai, Zhaohui, et al.
Publicado: (2019)

SARS-CoV-2 related liver impairment – perception may not be the reality
por: Philips, Cyriac Abby, et al.
Publicado: (2020)

A good response to glucocorticoid for Henoch–Schönlein purpura with abdominal pain and gastrointestinal bleeding in an adult: A CARE case report
por: Yi, Fangfang, et al.
Publicado: (2020)

Association of endoscopic variceal treatment with portal venous system thrombosis in liver cirrhosis: a case–control study
por: Wang, Le, et al.
Publicado: (2022)

Successful Pharmacotherapy for Multiple Acute Decompensation Events in a Cirrhotic Patient with Acute-on-chronic Liver Failure: A Case Report
por: Xu, Xiangbo, et al.
Publicado: (2018)

Antibiotics in Chronic Liver Disease and Their Effects on Gut Microbiota
por: Mendez-Sanchez, Nahum, et al.
Publicado: (2023)

Dangerous Placebo During the COVID-19 Pandemic: A Series of Homoeopathic Arsenicum Album-Induced Liver Injury
por: Theruvath, Arif H, et al.
Publicado: (2022)

“Seek and find” or “search and destroy?” Identifying and retaining “healthy” stool donors for fecal microbiota transplantation
por: Philips, Cyriac Abby
Publicado: (2023)

Covered TIPS for secondary prophylaxis of variceal bleeding in liver cirrhosis: A systematic review and meta-analysis of randomized controlled trials
por: Qi, Xingshun, et al.
Publicado: (2016)

Risk Factors for Esophageal Collateral Veins in Cirrhosis with and without Previous Endoscopic Esophageal Variceal Therapy
por: Li, Qianqian, et al.
Publicado: (2022)

Esophageal collateral veins in predicting esophageal variceal recurrence and rebleeding after endoscopic treatment: a systematic review and meta-analysis
por: Li, Qian-Qian, et al.
Publicado: (2020)

Clinical significance of neutrophil extracellular traps biomarkers in thrombosis
por: Xu, Xiangbo, et al.
Publicado: (2022)

Transient portal vein thrombosis in liver cirrhosis
por: Qi, Xingshun, et al.
Publicado: (2018)

Sorafenib for the treatment of hepatocellular carcinoma with portal vein tumour thrombosis: a systematic review of comparative studies
por: Qi, Xingshun, et al.
Publicado: (2015)

Severe fatty liver disease and acute pancreatitis: is there a correlation between them?
por: Qi, Xingshun, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_qctlb4hqk6thgab1c51hkosm60